Key Documents

View All Documentation

B2761

5-Bromoindole-2-carboxylic acid

Name: 5-Bromoindole-2-carboxylic acid
Brand: ALDRICH

98%

Synonym(s):

NSC 73384

Select a Size

Change View

About This Item

Linear Formula:

C₉H₆NO₂Br

CAS Number:

7254-19-5

Molecular Weight:

240.05

NACRES:

NA.22

PubChem Substance ID:

57653927

UNSPSC Code:

12352100

MDL number:

MFCD00022705

Assay:

98%

Form:

powder

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

Quality Level

200

assay

98%

form

powder

storage temp.

−20°C

SMILES string

OC(=O)c1cc2cc(Br)ccc2[nH]1

InChI

1S/C9H6BrNO2/c10-6-1-2-7-5(3-6)4-8(11-7)9(12)13/h1-4,11H,(H,12,13)

InChI key

YAULOOYNCJDPPU-UHFFFAOYSA-N

Description

Application

Reactant involved in studies of biologically active molecules including:

Discovery of indole inhibitors of MMP-13 for treatment of arthritic diseases
Synthesis of indolyl ethanones as indoleamine 2,3-dioxygenase inhibitors
cis-Diaminocyclohexane derivatives prepared for use as factor Xa inhibitors
Synthesis of tubulin polymerization inhibitors and cancer cell growth inhibitors
Preparation of dual PPARγ/δ agonists
Synthesis of chemical probes to examine the role of hFPRL1 receptor in inflammation

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel.

Shahrbanoo Jahangir et al.

Stem cell research & therapy, 11(1), 436-436 (2020-10-11)

Mesenchymal stem cells are a promising cell source for chondrogenic differentiation and have been widely used in several preclinical and clinical studies. However, they are prone to an unwanted differentiation process towards hypertrophy that limits their therapeutic efficacy. Matrix metallopeptidase

Global Trade Item Number

SKU	GTIN
B2761-1G	04061825759692